Q3 2018 Earnings Estimate for Cronos Group Inc. (MJN) Issued By Beacon Securities
Cronos Group Inc. (CVE:MJN) – Analysts at Beacon Securities lowered their Q3 2018 EPS estimates for Cronos Group in a note issued to investors on Friday. Beacon Securities analyst V. Ajamain now anticipates that the company will earn $0.00 per share for the quarter, down from their prior estimate of $0.01. Beacon Securities also issued estimates for Cronos Group’s Q4 2018 earnings at $0.00 EPS, Q1 2019 earnings at $0.01 EPS, Q2 2019 earnings at $0.01 EPS and Q3 2019 earnings at $0.02 EPS.
Shares of Cronos Group (MJN) opened at C$4.18 on Monday. Cronos Group has a 12-month low of C$1.35 and a 12-month high of C$4.78.
Cronos Group, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canadas Marihuana for Medical Purposes Regulations (MMPR). The firm typically invests in companies based in Canada.
Receive News & Ratings for Cronos Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.